Shvartsbart; Artem
Patent Applications and Registrations
Patent applications and USPTO patent grants for Shvartsbart; Artem.The latest application filed is for "heterocyclic compounds as pi3k-y inhibitors".
- Shvartsbart; Artem - Kennett Square PA
- SHVARTSBART; Artem - Wilmington DE
| Patent | Date |
|---|---|
| HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20220251087 - Buesking; Andrew W. ; et al. | 2022-08-11 |
| TERTIARY ALCOHOLS AS PI3K-y INHIBITORS App 20220213107 - Douty; Brent ; et al. | 2022-07-07 |
| 3-(5-amino-pyrazin-2-yl)-benzenesulfonamide derivatives and related compounds as PI3K-gamma kinase inhibitors Grant 11,306,079 - Shvartsbart , et al. April 19, 2 | 2022-04-19 |
| Tertiary alcohols as PI3K-.gamma. inhibitors Grant 11,225,486 - Douty , et al. January 18, 2 | 2022-01-18 |
| Heterocyclic Derivatives As Pi3k Inhibitors App 20210395258 - Shepard; Stacey ; et al. | 2021-12-23 |
| Fused Tricyclic Kras Inhibitors App 20210355121 - ZHU; Wenyu ; et al. | 2021-11-18 |
| Heterocyclic derivatives as PI3K inhibitors Grant 11,161,838 - Shepard , et al. November 2, 2 | 2021-11-02 |
| Heterocyclic compounds as PI3K-y inhibitors Grant 11,091,491 - Shvartsbart , et al. August 17, 2 | 2021-08-17 |
| Heterocyclic derivatives as PI3K inhibitors Grant 11,078,204 - Shepard , et al. August 3, 2 | 2021-08-03 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20210214366 - Roach; Jeremy ; et al. | 2021-07-15 |
| Aminopyrazine derivatives as PI3K-.gamma. inhibitors Grant 11,046,658 - Douty , et al. June 29, 2 | 2021-06-29 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20210115053 - Shvartsbart; Artem ; et al. | 2021-04-22 |
| Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors Grant 10,975,088 - Buesking , et al. April 13, 2 | 2021-04-13 |
| TERTIARY ALCOHOLS AS PI3K-y INHIBITORS App 20200385392 - Douty; Brent ; et al. | 2020-12-10 |
| 3-(5-amino-pyrazin-2-yl)-benzenesulfonamide Derivatives And Related Compounds As Pi3k-gamma Kinase Inhibitors For Treating E.g. Cancer App 20200331903 - SHVARTSBART; Artem ; et al. | 2020-10-22 |
| Tertiary alcohols as PI3K-.gamma. inhibitors Grant 10,738,057 - Douty , et al. A | 2020-08-11 |
| Heterocyclic Derivatives As Pi3k Inhibitors App 20200148689 - Shepard; Stacey ; et al. | 2020-05-14 |
| Heterocyclic Derivatives As Pi3k Inhibitors App 20200148671 - Shepard; Stacey ; et al. | 2020-05-14 |
| HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20200102315 - Buesking; Andrew W. ; et al. | 2020-04-02 |
| HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20200031837 - Shvartsbart; Artem ; et al. | 2020-01-30 |
| AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS App 20200002295 - Douty; Brent ; et al. | 2020-01-02 |
| Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors Grant 10,479,795 - Buesking , et al. Nov | 2019-11-19 |
| Heterocyclic compounds as PI3K-.gamma. inhibitors Grant 10,472,368 - Shvartsbart , et al. Nov | 2019-11-12 |
| TERTIARY ALCOHOLS AS PI3K-y INHIBITORS App 20190152975 - Douty; Brent ; et al. | 2019-05-23 |
| HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20190062336 - Shvartsbart; Artem ; et al. | 2019-02-28 |
| Heterocyclic compounds as PI3K-.gamma. inhibitors Grant 10,065,963 - Shvartsbart , et al. September 4, 2 | 2018-09-04 |
| HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS App 20170129899 - Shvartsbart; Artem ; et al. | 2017-05-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 